Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ITGR
BUYInteger Holdings Corporation · Healthcare · United States · $3.3B · Avg Vol: $44M/d
COMPANY DESCRIPTION
Integer Holdings is a leading medical device outsource (MDO) manufacturer specializing in high-quality components and finished devices for cardiac, neuromodulation, vascular, and orthopedic markets. It benefits from deep expertise in highly specialized medical device manufacturing, stringent quality systems, and long-standing relationships with top-tier OEMs. The company is a critical supply chain partner, enabling innovation and production of life-saving and enhancing medical technologies.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.3B | 1.6B | 1.7B | 1.9B | 11.7% | 1.9B | 1.8B | 1.9B | 1.9% |
| EPS | 2.00 | 2.72 | 3.57 | 2.96 | 14.0% | 4.03 | 2.81 | 3.15 | 3.2% |
| Shares | 33.2M | 33.3M | 33.5M | 34.3M | +3.5% | 34.0M | — | — | — |
| Debt | 1.0B | 1.1B | 1.1B | 1.3B | 9.2% | 1.4B | — | — | — |
| Equity | 1.4B | 1.5B | 1.6B | 1.7B | 7.2% | — | — | — | — |
| Op CF | 116.4M | 180.2M | 205.2M | 196.1M | 19.0% | 189.6M | — | — | — |
| Inv CF | -200.4M | -163.4M | -195.4M | -270.7M | — | — | — | — | — |
| Fin CF | 92.5M | -18.0M | 13.3M | 43.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ITGR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ITGR | Integer Holdings Corporation(you) | $3.3B | 72 | BUY |
| UFPT | UFP Technologies, Inc. | $1.8B | 75 | BUY |
| HAE | Haemonetics Corporation | $3.6B | 89 | STRONG BUY |
| BIO-B | Bio-Rad Laboratories, Inc. | $8.3B | 72 | BUY |
| AXGN | Axogen, Inc. | $2.1B | 62 | HOLD |
| AVNS | Avanos Medical, Inc. | $1.2B | 72 | BUY |
| ENOV | Enovis Corporation | $1.6B | 80 | BUY |
| IART | Integra LifeSciences Holdings Corporation | $1.5B | 80 | BUY |
| AHCO | AdaptHealth Corp. | $1.5B | 79 | BUY |
| IRMD | IRADIMED CORPORATION | $1.2B | 78 | BUY |
Peer medians: ROE -25.6% · P/E 27.9x · Gross margin 50.7%